)
Edge12 Jun 2026
Set in Stone: The Story of Richemont
From a South African tobacco company to Cartier, a deep dive into how Richemont built one of the world's leading hard luxury empires.
Ocular Therapeutix
Ocular Therapeutix (OCUL) investor relations material
Ocular Therapeutix AGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.AGM 2026 summary10 Jun, 2026
Opening remarks and agenda
The meeting was called to order by the CEO, with introductions of board members, nominees, and key company representatives.
The meeting was held virtually to maximize stockholder participation, with rules of conduct and participation explained.
Board and executive committee updates
Board members and nominees for director positions were introduced, including the CEO and Merilee Raines.
Shareholder proposals
Proposals included election of Class III directors, advisory votes on executive compensation and its frequency, amendment to the 2021 Stock Incentive Plan, and ratification of the accounting firm.
Implications of the 74% say-on-pay approval
Impact of the 10 million share plan increase
Significance of the 86% quorum participation
Analyze the 74% executive compensation approval
Assess the 10 million share plan expansion
Evaluate the significance of the 86% quorum
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Ocular Therapeutix
- SOL-1 achieved FDA-aligned superiority, with rapid adoption and broad label ambitions.OCUL
Stifel 2026 Virtual Ophthalmology Forum26 May 2026 - SOL-1 demonstrated superior efficacy and durability, paving the way for broad adoption and regulatory filing.OCULBank of America Global Healthcare Conference 202613 May 2026
- AXPAXLI's Phase 3 success in wet AMD drives NDA plans amid rising R&D costs and strong cash reserves.OCULQ1 20265 May 2026
- Superiority study results support a unique label, broad indications, and strong commercial prospects.OCULTD Cowen 46th Annual Health Care Conference5 May 2026
- AXPAXLI achieved unprecedented 12-month durability and superiority in wet AMD with strong safety.OCULStudy update3 May 2026
- Proposals cover director elections, executive pay, stock plan expansion, and auditor ratification.OCULProxy filing30 Apr 2026
- Key clinical, financial, and governance advances set the stage for long-term growth and value creation.OCULProxy filing30 Apr 2026
- AXPAXLI is poised for broad adoption in wet AMD, backed by robust clinical data and a strong commercial strategy.OCULHCW @ Home27 Apr 2026
- AXPAXLI showed phase III superiority over anti-VEGF, with strong regulatory and clinical momentum.OCULRBC Capital Markets Virtual Ophthalmology Conference25 Mar 2026
Next Ocular Therapeutix earnings date
Investor Day 202617 Jun, 2026
Ocular Therapeutix
Next Ocular Therapeutix earnings date
Investor Day 202617 Jun, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage